ContractClinical Trial Agreement • February 22nd, 2018
Contract Type FiledFebruary 22nd, 2018AMENDMENT NO. 5 TO CLINICAL TRIAL AGREEMENT DODATEK Č. 5 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ THIS AMENDMENT AGREEMENT NO. 5 ismade effective as of the date of publication in accordance with the Act No. 340/2015 Coll. (the “Effective Date”) by and between: TENTO DODATEK KE SMLOUVĚ Č. 5 nabýváúčinnosti uveřejněním v registru smluv (dále„Datum účinnosti”) mezi: Biogen Idec Ltd, located at Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, United Kingdom (together with its subsidiaries and affiliates, “Biogen Idec”), and společností Biogen Idec Ltd, se sídlem Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, Spojené království (dále společně se všemi dceřinými a sesterskými společnostmi jen “Biogen Idec”), a Krajská zdravotní, a.s., located at Sociální péče 3316/12a, 401 13 Ústí nad Labem, Czech Republic, Identification number: 254 88 627, Tax identification number: CZ25488627, represented by Ing. Petr Fiala, Managing director (the “Institution”), and Krajskou z